Psi Advisors, LLC Bristol Myers Squibb CO Transaction History

Psi Advisors, LLC

$338 Million
Q3 2024

A detailed history of Psi Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Psi Advisors, LLC holds 5,950 shares of BMY stock, worth $343,196. This represents 0.09% of its overall portfolio holdings.

Number of Shares

5,950

Previous 6,730 11.59%

Holding current value

$343,196

Previous $279,000 10.04%

% of portfolio

0.09%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$39.66 - $51.75 $30,934 - $40,365	-780 Reduced 11.59%	5,950 $307,000
Q2 2024 Jul 23, 2024	BUY	$40.25 - $52.99 $27,933 - $36,775	694 Added 11.5%	6,730 $279,000
Q1 2024 Apr 24, 2024	BUY	$47.98 - $54.4 $9,404 - $10,662	196 Added 3.36%	6,036 $327,000
Q4 2023 Feb 01, 2024	SELL	$48.48 - $57.85 $18,228 - $21,751	-376 Reduced 6.05%	5,840 $299,000
Q3 2023 Oct 13, 2023	BUY	$57.89 - $64.73 $63,157 - $70,620	1,091 Added 21.29%	6,216 $360,000
Q2 2023 Jul 21, 2023	BUY	$63.71 - $70.74 $30,134 - $33,460	473 Added 10.17%	5,125 $327,000
Q1 2023 Apr 25, 2023	BUY	$65.71 - $74.53 $65 - $74	1 Added 0.02%	4,652 $322,000
Q4 2022 Jan 19, 2023	SELL	$68.48 - $81.09 $276,453 - $327,360	-4,037 Reduced 46.47%	4,651 $0
Q3 2022 Oct 20, 2022	SELL	$0.13 - $76.84 $505 - $298,830	-3,889 Reduced 30.92%	8,688 $618,000
Q2 2022 Jul 18, 2022	SELL	$72.62 - $79.98 $44,516 - $49,027	-613 Reduced 4.65%	12,577 $968,000
Q1 2022 Apr 20, 2022	SELL	$61.48 - $73.72 $133,165 - $159,677	-2,166 Reduced 14.11%	13,190 $963,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $40,168 - $46,827	-749 Reduced 4.65%	15,356 $958,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $14,970 - $17,535	-253 Reduced 1.55%	16,105 $953,000
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $15,848 - $17,259	256 Added 1.59%	16,358 $1.09 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $162,354 - $182,600	2,736 Added 20.47%	16,102 $1.02 Million
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $97,927 - $110,969	1,696 Added 14.53%	13,366 $829,000
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $23,086 - $25,583	402 Added 3.57%	11,670 $703,000
Q2 2020 Aug 04, 2020	BUY	$54.82 - $64.09 $128,881 - $150,675	2,351 Added 26.37%	11,268 $662,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $35,588 - $51,718	-767 Reduced 7.92%	8,917 $497,000
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $476,549 - $621,615	9,684 New	9,684 $621,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Psi Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Psi Advisors, LLC with notifications on news.

Account